Reporter Gene Assay Market Forecast 2024-2033

 Overview and Scope

The reporter gene assay market consists of revenues earned by entities by providing services such as cell culture services, assay development, assay validation, high-throughput screening, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The reporter gene assay market also includes consists sales of transfection reagents, reporter gene detection kits, assay validation controls, assay optimization kits, and high-throughput screening platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Sizing and Forecast
The reporter gene assay market size has grown strongly in recent years. It will grow from $5.88 billion in 2023 to $6.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising demand for cell-based assays, rise in genomics research, increased drug discovery and development research, rising need for personalized treatment, and demand for early diagnosis.



The reporter gene assay market size is expected to see strong growth in the next few years. It will grow to $9.03 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the rising prevalence of chronic genetic disorders, growing demand for personalized medicine, growing use of molecular imaging systems, expansion of gene therapy portfolios, and government initiatives. Major trends in the forecast period include technological advancements in gene therapy, advancements in molecular biology, demand for advanced molecular diagnostic tools, shift towards 3d cell culture models, and strategic partnerships

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/reporter-gene-assay-global-market-report 

Segmentation & Regional Insights
The reporter gene assay market covered in this report is segmented –

1) By Product: Assay Kits, Reagents
2) By Application: Promoter Structural And Functional Analysis, Cell Signaling Pathways, Protein Interaction, Clinical And Gene Regulation
3) By End-User: Biotechnology And Pharmaceutical Companies, Research And Academic Institutes, Hospital And Diagnostic Laboratories, Contract Research Organizations

North America was the largest region in the reporter gene assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the reporter gene assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16526&type=smp 

Major Driver Impacting Market Growth
The increasing drug discovery and development research is expected to propel the growth of the reporter gene assay market. Drug discovery and development research refers to the systematic process within the medical, biotechnology, and pharmacology fields that leads to identifying, creating, and introducing new medications to the market. The increasing drug discovery and development research is due to advancements in proteomics, high-throughput screening, genomics, and novel medications' successful development and approval. Reporter gene assays serve as valuable tools in discovery and development research, enabling researchers to gain insights into gene regulation, identify potential drug targets, screen compound libraries, and evaluate the efficacy and safety of candidate drugs. For instance, in April 2024, according to the Office for National Statistics, a UK-based government department, the UK government's net expenditure on research and development (R&D) rose to £15.5 billion ($19.7 billion) in 2022 from £14.0 billion ($17.8 billion) in 2021, an increase of 10.5%. Therefore, increasing drug discovery and development research is driving the growth of the reporter gene assay market.

Key Industry Players
Major companies operating in the reporter gene assay market are Roche Diagnostics, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD Biosciences), GE Healthcare, Lonza Group, Agilent Technologies, Sartorius AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GenScript Biotech Corporation, Abcam plc, Promega Corporation, Promega Corporation, Takara Bio Inc., New England Biolabs (NEB), OriGene Technologies Inc., Cell Signaling Technology Inc., SABiosciences, Enzo Biochem Inc., InvivoGen, Biotium Inc., Enzo Life Sciences Inc., BioAssay Systems, Indigo Biosciences Inc.

The reporter gene assay market report table of contents includes:


1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis


Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 

Comments

Post a Comment

Popular posts from this blog

Chillers Market Outlook 2024-2033: Trends and Projections

Image
  Market Size - The chillers market size has grown steadily in recent years. It will grow from $9.04 billion in 2023 to $9.43 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to growth in industrial and commercial construction, expansion of hvacr systems in residential and commercial buildings, adoption of process cooling in industrial applications, increased in demand for air conditioning and refrigeration, focus on energy efficiency and sustainable cooling solutions. The chillers market size is expected to see strong growth in the next few years. It will grow to $11.68 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to urbanization and growth of megacities driving demand for cooling solutions, expansion of data centers and it infrastructure, adoption of chillers in food and beverage processing, demand for district cooling systems in urban develo...
Read more

Integrated Pest Management IPM Market Outlook 2024-2033: Trends and Projections

Image
  Market Size - The integrated pest management (ipm) market size has grown strongly in recent years. It will grow from $124.96 billion in 2023 to $134.68 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to environmental concerns, regulatory pressures, consumer demand, cost savings. The integrated pest management (ipm) market size is expected to see strong growth in the next few years. It will grow to $184.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to climate change impact, global food security concerns, collaborative initiatives, . Major trends in the forecast period include technology advancements, market expansion, biological control methods, digital agriculture integration, crop-specific ipm solutions, biotechnology innovations, focus on non-chemical alternatives, certification programs. Order your report now for swift delivery @ https:...
Read more

Congenital Heart Defect Devices Market Outlook 2024-2033: Trends and Projections

Image
  Market Size -   The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure. The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $3.86 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast per...
Read more